Emyria Ltd (AU:EMD) — Market Cap & Net Worth
Market Cap & Net Worth: Emyria Ltd (EMD)
Emyria Ltd (AU:EMD) has a market capitalization of $23.40 Million (AU$33.07 Million) as of June 17, 2026. Listed on the AU stock exchange, this Australia-based company holds position #24616 globally and #1003 in its home market, demonstrating a -8.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emyria Ltd's stock price AU$0.04 by its total outstanding shares 806556529 (806.56 Million). Review how much debt does Emyria Ltd carry to assess the company's total debt and financial obligations.
Emyria Ltd Market Cap History: 2020 to 2026
Emyria Ltd's market capitalization history from 2020 to 2026. Data shows change from $52.50 Million to $23.40 Million (-18.06% CAGR).
Emyria Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emyria Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
24.14x
Emyria Ltd's market cap is 24.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $52.50 Million | $1.01 Million | -$5.24 Million | 51.81x | N/A |
| 2021 | $219.72 Million | $1.98 Million | -$4.91 Million | 111.20x | N/A |
| 2022 | $97.02 Million | $1.82 Million | -$7.33 Million | 53.24x | N/A |
| 2023 | $29.68 Million | $1.59 Million | -$5.13 Million | 18.64x | N/A |
| 2024 | $19.40 Million | $2.20 Million | -$11.46 Million | 8.81x | N/A |
| 2025 | $33.67 Million | $1.39 Million | -$3.14 Million | 24.14x | N/A |
Competitor Companies of EMD by Market Capitalization
Companies near Emyria Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Emyria Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1025 globally with a market cap of $26.34 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1952 globally with a market cap of $12.16 Billion USD ( AU$17.19 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2170 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2418 globally with a market cap of $9.09 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1025 | Veeva Systems Inc Class A | NYSE:VEEV | $26.34 Billion | $162.17 |
| #1952 | Pro Medicus Ltd | AU:PME | $12.16 Billion | AU$164.55 |
| #2170 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.08 |
| #2418 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.09 Billion | $52.32 |
Emyria Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Emyria Ltd's market cap moved from $52.50 Million to $ 23.40 Million, with a yearly change of -18.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$23.40 Million | -30.51% |
| 2025 | AU$33.67 Million | +73.53% |
| 2024 | AU$19.40 Million | -34.62% |
| 2023 | AU$29.68 Million | -69.41% |
| 2022 | AU$97.02 Million | -55.84% |
| 2021 | AU$219.72 Million | +318.48% |
| 2020 | AU$52.50 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Emyria Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.40 Million USD |
| MoneyControl | $23.40 Million USD |
| MarketWatch | $23.40 Million USD |
| marketcap.company | $23.40 Million USD |
| Reuters | $23.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Emyria Ltd
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more